Toxic epidermal necrolysis caused by flurazepam?

Psychiatria Danubina

Volumn 17, Issue 3-4, 2005, Pages 236-239

  Lončar, Časlav ^a   Franić, Tomislav ^a   Bilušić, Marijo ^b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Drug hypersensitivity; Flurazepam; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; BIPERIDEN; CARBAMAZEPINE; CLOZAPINE; DIAZEPAM; FLUPHENAZINE; FLURAZEPAM; METHYLPREDNISOLONE; OLANZAPINE; PROMAZINE; RISPERIDONE;

ADULT; ANURIA; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; FEMALE; FEVER; FLUID THERAPY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; PAPULAR SKIN DISEASE; SCHIZOPHRENIA; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SUPERINFECTION; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; FLURAZEPAM; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; PATIENT ADMISSION; SCHIZOPHRENIA, PARANOID;

EID: 28844484068     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chan HL, Stern RS, Arndt KA, et al: The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126:43-7.
2. Correia O, Chosidow O, Saiag P, Bastuji-Garin S, Revuz J, Roujeau J-C: Evolving pattern of drug-induced toxic epidermal necrolysis. Dermatology 1993; 186:32-7.
3. Foster CS, Fong LP, Azar D, Kenyon KR: Episodic conjunctival inflammation after Stevens-Johnson syndrome. Ophthalmology 1988; 95(4): 453-62
4. Hart R, Minto C, Creighton S: Vaginal adhesions caused by Stevens-Johnson syndrome. J Pediatr Adolesc Gynecol 2002; 15:151-152.
5. Knowles RS, Uetrecht J, Shear HN: Idiosyncratic drug reactions: the reactive metabolite syndromes. The Lancet 2000; 356: 1587-1591.
6. Layell A: Toxic epidermal necrolysis (the scaled skin syndrome): a reappraisal. Br J dermatol 1979; 100:69-86.
7. Naldi L, Locati F, Marchesi L, Cainelli T: Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol 1990; 126:1103-4.
8. Power W, Ghoraishi M, Merayo-Lloves J, Neves R, Foster C: Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 1995; 102(11):1669-1676.
9. Roujeau JC, Chosidow O, Saiag P, Guillaume JC: Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990; 23: 1039-58.
10. Roujeau J-C, Guillaume J-C, Fabre J-P, Penso D, Flechet ML, Girre JP: Toxic epidermal necrolysis (Lyell syndrome): incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990; 126:37-42.
11. Roujeau JC, Kelly JP, Naldi L, et al: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333(24): 1600-7.
12. Roujeau JC: Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 1997; 24(11): 726-9.
13. Rzany B, Correia O, Kelly P J, Naldi L, Auquier A, Stern R: Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case control study. The Lancet 1990; 353: 2190-94.
14. Schöpf E, Stühmer A, Rzany B, Victor N, Zentgraf R, Kapp JF: Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany. Arch Dermatol 1991; 127:839-42.